Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
Works by Gural, Alex
Results: 4
1
2
Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-022-06982-7
- By:
- Publication type:
- Article
3
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 131, doi. 10.1002/ajh.24596
- By:
- Publication type:
- Article
4
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article